RG-101: Additional Phase II data

Data from 78 evaluable treatment-naive patients with chronic HCV genotype 1 or 4 infection in an open-label, European Phase II trial

Read the full 210 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE